Related Experiment Video
Updated: Jan 16, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Oncology Drug Shortages: Impacts, Policy Reforms, and Advocacy Imperatives
Marissa Malta1, Matthew Christian, Amy B Cadwallader
1US Pharmacopeia, Global External Affairs, 12601 Twinbrook Parkway, Rockville, MD.
Oncology drug shortages are critically impacting cancer patient care. This study analyzes supply chain issues and proposes policy reforms for sustainable pharmaceutical supply chain resilience.
Area of Science:
- Oncology
- Pharmaceutical Sciences
- Health Policy
Background:
- Oncology drug shortages have reached unprecedented levels.
- These shortages significantly impact cancer patient treatment, leading to rationing, delays, and suboptimal therapies.
Purpose of the Study:
- To outline systemic drivers of pharmaceutical supply chain vulnerabilities causing drug shortages.
- To present data analyses of ongoing oncology drug shortages.
- To propose actionable policy reforms for patient advocacy and supply chain resilience.
Main Methods:
- Systemic analysis of supply chain vulnerabilities.
- Data analysis of current medicine supply chain shortages.
- Development of policy recommendations for pharmaceutical supply chain reform.
Main Results:
- Identified key systemic drivers contributing to oncology drug shortages.
- Analyzed current trends and patterns in medicine supply chain disruptions.
- Formulated policy recommendations to enhance pharmaceutical supply chain sustainability.
Conclusions:
- Addressing systemic vulnerabilities is crucial for mitigating oncology drug shortages.
- Policy reforms are necessary to ensure patient access to essential cancer treatments.
- Building a resilient pharmaceutical supply chain requires sustainable, long-term strategies.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Drug Control Governance: Regulatory Bodies and Their Impact
Treatment Resistant Cancers
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Drug Regulation
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...

